Exascale Labs Reports 111% Revenue Growth to $14.8M and $300M Pipeline in First Post-Merger Results
XLAB is trading near its 52-week low of $2.01 (9.5% above the low) on light trading volume (0.3× avg).
Summary
Exascale Labs reported FY2026 revenue of $14.8 million, up 111% year-over-year, alongside a $12.2 million net loss and a $300 million qualified customer pipeline. The company also named Jake Carney as CFO.
Key Events · Earnings and Guidance · XLAB
-
Revenue Doubles to $14.8M
FY2026 revenue grew 111.3% to $14.8 million from $7.0 million in FY2025, driven by a 124% increase in intelligent computing power service revenue.
-
Net Loss Widens to $12.2M
Net loss increased to $12.2 million from $7.7 million, including a $7.4 million non-cash fair value adjustment on SAFEs that converted to equity at the merger close.
-
Cash Position and Merger Proceeds
Cash was $2.7 million at June 30, 2026, supplemented by approximately $11.8 million in net proceeds from the August 27 business combination.
-
$300M Qualified Pipeline
CEO Hoansoo Lee disclosed a qualified customer pipeline of approximately $300 million, though the LOI with Compal and MOU with EnergyBank remain non-binding.
Analysis · XLAB · Technology
Exascale's first full-year results as a public company show revenue more than doubling to $14.8 million, but the net loss widened to $12.2 million and the company held only $2.7 million in cash at fiscal year-end. The $11.8 million in net proceeds from the August SPAC merger provides runway, but the $300 million qualified pipeline is still non-binding — converting those opportunities into signed contracts is the key execution risk. The appointment of Jake Carney as CFO on September 25 adds a permanent finance lead after the interim CFO arrangement.
How filings like this one have moved
In the 30 days to Nov 1, 2026, 32.5% of the 1969 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XLAB was trading at $2.20 on NASDAQ in the Technology sector, with a market capitalization of approximately $68.5M. The 52-week trading range was $2.01 to $11.17. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.